Cure8 news brief
People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help detect recurrence and guide decisions about further testing or treatment.
Adults with Crohn's disease who have an ileostomy, clinicians who manage postoperative IBD patients, and researchers studying biomarkers for IBD monitoring.
The researchers analyzed retrospective data from patients with an ileostomy who had FC measured at the same time as imaging or endoscopy. FC concentrations from ileostomy output were higher when objective evidence showed active small-bowel inflammation.
The study compared a point-of-care FC test (FC-POCT) and an ELISA (FC-ELISA) and found no clear difference in diagnostic performance between them.
How this might affect care: If validated in prospective studies, measuring FC from ileostomy output could offer a noninvasive way to monitor postoperative small-bowel inflammation and help guide when to pursue imaging, endoscopy, or treatment adjustments.
This research does not itself change care but points to a potential monitoring option for patients with ileostomies. Practical note: The article calls for further prospective work and standardized FC thresholds before routine clinical use.
This report summarizes a retrospective single-study analysis; it is not a randomized trial. Authors note the need for prospective validation and standardized thresholds before FC from ileostomy output can be recommended for routine clinical practice.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Faecal calprotectin from ileostomy output could provide a non-invasive way to detect small-bowel inflammation after surgery, helping to guide monitoring and reduce reliance on invasive tests for postoperative Crohn’s...
People with Crohn’s disease who have an ileostomy have limited noninvasive ways to monitor small-bowel inflammation. This study suggests measuring fecal calprotectin from ileostomy output could help detect postoperative...
Noninvasive tests at 3 months after ileocecal resection (ultrasound + fecal calprotectin) may identify patients at high risk of endoscopic recurrence by 6 months. That could help avoid or target postoperative endoscopy...
